Phosphatidylethanolamine Binding Protein
"Phosphatidylethanolamine Binding Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A ubiquitously found basic protein that binds to phosphatidylethanolamine and NUCLEOTIDES. It is an endogenous inhibitor of RAF KINASES and may play a role in regulating SIGNAL TRANSDUCTION. Phosphatidylethanolamine-binding protein is the precursor of hippocampal cholinergic neurostimulating peptide, which is cleaved from the N-terminal region of the protein.
| Descriptor ID |
D049488
|
| MeSH Number(s) |
D12.644.360.562 D12.776.157.661 D12.776.476.555
|
| Concept/Terms |
Phosphatidylethanolamine Binding Protein- Phosphatidylethanolamine Binding Protein
- Hippocampal Cholinergic Neurostimulating Peptide Precursor
- HCNP Precursor Protein
- Raf Kinase Inhibitor Protein
- Phosphatidylethanolamine-Binding Protein
|
Below are MeSH descriptors whose meaning is more general than "Phosphatidylethanolamine Binding Protein".
Below are MeSH descriptors whose meaning is more specific than "Phosphatidylethanolamine Binding Protein".
This graph shows the total number of publications written about "Phosphatidylethanolamine Binding Protein" by people in this website by year, and whether "Phosphatidylethanolamine Binding Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphatidylethanolamine Binding Protein" by people in Profiles.
-
MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP. Cell Physiol Biochem. 2017; 41(3):1135-1146.
-
Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy. Ophthalmic Plast Reconstr Surg. 2015 Jul-Aug; 31(4):e112-5.
-
cis-Acting elements and trans-acting factors in the transcriptional regulation of raf kinase inhibitory protein expression. PLoS One. 2013; 8(12):e83097.
-
RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett. 2010 Feb 19; 584(4):662-8.
-
Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery. 2004 Sep; 136(3):708-15.